Tuesday, 02 January 2024 12:17 GMT

South Korea Biophotonics Market - Size, Trends, And Strategic Forecast, 2026-2031 AI-Enabled Diagnostics And Precision Medicine Drive 7.0% CAGR To USD 7.1 Billion


(MENAFN- GlobeNewsWire - Nasdaq) Unlock ROI through market entry, geographic expansion, competitive intelligence, AI-enabled imaging, precision diagnostics and strategic R&D partnerships.

Dublin, Oct. 01, 2026 (GLOBE NEWSWIRE) -- "South Korea Biophotonics Market - Strategic Insights and Forecasts (2026-2031)" has been added to ResearchAndMarkets.com's offering.

The South Korea biophotonics market is projected to grow from USD 5.0 billion in 2026 to USD 7.1 billion by 2031, representing a compound annual growth rate of 7.0%. Market expansion is being supported by the increasing use of advanced optical technologies across healthcare, medical diagnostics, biomedical research, drug discovery, and life sciences.

South Korea offers a favorable environment for biophotonics innovation through its established semiconductor and electronics manufacturing industries, advanced healthcare infrastructure, and strong biomedical research ecosystem. Growing demand for precision medicine, non-invasive diagnostic procedures, high-resolution imaging, and early disease detection is accelerating the adoption of optical imaging, spectroscopy, biosensors, and light-based therapeutic systems.

South Korea Biophotonics Market Drivers

The rising prevalence of cancer, neurodegenerative conditions, and other chronic diseases is increasing demand for sensitive and accurate medical diagnostic platforms. Optical coherence tomography, fluorescence imaging, spectroscopy, and related technologies support early detection, real-time tissue analysis, and improved clinical decision-making. These capabilities are expanding the role of biophotonics in oncology, ophthalmology, digital pathology, and other diagnostic specialties.

Government investment in biomedical research and healthcare innovation is another important market driver. Funding provided to universities, national research institutions, and life sciences programs is generating demand for advanced microscopy systems, optical biosensors, and high-speed spectroscopic instruments. These technologies are increasingly used in molecular biology, drug discovery, and laboratory research.

South Korea's semiconductor and display manufacturing capabilities also strengthen the domestic biophotonics supply chain. Local access to high-quality lasers, optical sensors, precision optics, and related photonic components supports the development and integration of advanced diagnostic and research systems.

Market Challenges

High capital costs remain a significant barrier to broader adoption. Advanced imaging equipment, laser modules, and high-resolution microscopes require substantial investment, potentially limiting procurement by smaller hospitals, laboratories, and biotechnology startups.

The market also depends on international suppliers for certain high-performance detectors, specialized lasers, and optical systems. This exposure may contribute to price volatility, procurement delays, and supply chain uncertainty. In addition, biophotonic medical devices must comply with strict national safety, quality, and performance requirements, increasing development costs and potentially extending commercialization timelines.

Technology, Application, and End-user Insights

Major technology categories include imaging technologies, spectroscopy technologies, light-based therapeutics, biosensors, and bioassays. Imaging technologies account for a prominent share of market demand due to their importance in tissue visualization, cellular analysis, clinical imaging, and biomedical research.

Medical diagnostics represents the leading application segment, supported by expanding use in cancer detection, ophthalmology imaging, digital pathology, and precision diagnostics. The integration of artificial intelligence with optical imaging platforms is further improving image interpretation, workflow efficiency, and diagnostic accuracy.

Key end-user groups include hospitals and clinics, research institutions and laboratories, pharmaceutical companies, and environmental monitoring agencies. Research institutions remain influential early adopters of advanced microscopy and spectroscopy equipment for biomedical studies and drug development.

Competitive and Strategic Outlook

The South Korea biophotonics market includes global optical technology providers, diagnostic equipment manufacturers, and domestic photonics companies. International participants supply advanced microscopy and imaging platforms, while local businesses contribute through optical component production, biosensing technologies, and system integration.

Collaborations among healthcare providers, research institutions, universities, and technology companies are expected to support product development and commercialization. Continued innovation in artificial intelligence, optical imaging, precision diagnostics, and biosensing will create long-term opportunities despite cost, regulatory, and supply chain pressures.

Key Benefits of the Report

  • Detailed analysis of market segments, customer groups, policies, socio-economic factors, industry verticals, and regional opportunities
  • Assessment of competitive positioning and strategic activity among leading market participants
  • Evaluation of market drivers, constraints, supply chain conditions, and emerging technology trends
  • Actionable recommendations for market entry, investment planning, product development, and revenue growth
  • Relevant intelligence for startups, research institutions, consultants, SMEs, and large enterprises

Business Applications

Organizations can use the report for industry analysis, opportunity assessment, product demand forecasting, market entry strategy, geographical expansion, capital investment decisions, regulatory analysis, new product development, and competitive intelligence.

Report Coverage

  • Historical market data from 2021 to 2025 and forecasts from 2026 to 2031
  • Analysis of growth opportunities, challenges, supply chain outlook, regulatory framework, and market trends
  • Competitive strategies, market positioning, and market share evaluation
  • Revenue forecasts across technologies, applications, end-user groups, and regions
  • Company profiles covering strategies, products, financial performance, and key developments

Key Topics Covered:
1. EXECUTIVE SUMMARY
2. MARKET SNAPSHOT
2.1. Market Overview
2.2. Market Definition
2.3. Scope of the Study
2.4. Market Segmentation
3. BUSINESS LANDSCAPE
3.1. Market Drivers
3.2. Market Restraints
3.3. Market Opportunities
3.4. Porter's Five Forces Analysis
3.5. Industry Value Chain Analysis
3.6. Policies and Regulations
3.7. Strategic Recommendations
4. TECHNOLOGICAL OUTLOOK
5. SOUTH KOREA BIOPHOTONICS MARKET BY TECHNOLOGY
5.1. Introduction
5.2. Imaging Technologies
5.3. Spectroscopy Technologies
5.4. Light-Based Therapeutics
5.5. Biosensors and Bioassays
6. SOUTH KOREA BIOPHOTONICS MARKET BY APPLICATION
6.1. Introduction
6.2. Medical Diagnostics
6.3. Therapeutics
6.4. Research and Development
6.5. Environmental Monitoring
7. SOUTH KOREA BIOPHOTONICS MARKET BY END-USER
7.1. Introduction
7.2. Hospitals and Clinics
7.3. Research Institutions and Laboratories
7.4. Pharmaceutical and Biotechnology Companies
7.5. Environmental Agencies
8. COMPETITIVE ENVIRONMENT AND ANALYSIS
8.1. Major Players and Strategy Analysis
8.2. Market Share Analysis
8.3. Mergers, Acquisitions, Agreements, and Collaborations
8.4. Competitive Dashboard
9. COMPANY PROFILES
9.1. Park Systems
9.2. Lunit
9.3. QuantaMatrix
9.4. Cybermed
9.5. Hamamatsu Photonics
9.6. Carl Zeiss
9.7. Olympus Corporation
9.8. Thermo Fisher Scientific
9.9. Bruker
10. APPENDIX
10.1. Currency
10.2. Assumptions
10.3. Base and Forecast Years Timeline
10.4. Key Benefits for the Stakeholders
10.5. Research Methodology
10.6. Abbreviations
LIST OF FIGURES [0]
LIST OF TABLES [0]
Companies Featured

  • Park Systems
  • Lunit
  • QuantaMatrix
  • Cybermed
  • Hamamatsu Photonics
  • Carl Zeiss
  • Olympus Corporation
  • Thermo Fisher Scientific
  • Bruker

For more information about this report visit

About ResearchAndMarkets.com
ResearchAndMarkets.com is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.

CONTACT: CONTACT: ResearchAndMarkets.com Laura Wood,Senior Press Manager... For E.S.T Office Hours Call 1-917-300-0470 For U.S./ CAN Toll Free Call 1-800-526-8630 For GMT Office Hours Call +353-1-416-8900

MENAFN01102026004107003653ID1111743918



GlobeNewsWire - Nasdaq

Legal Disclaimer:
MENAFN provides the information “as is” without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the provider above.



More Story